Atrás
También listada como
RHHBY
OTC
Rango del Día
$378.00
$386.75
Rango de 52 Semanas
$288.90
$514.08
Volumen
3
Promedio 50D / 200D
$450.02
/
$384.75
Cierre Anterior
$385.00
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 23.9 | 0.2 |
| P/B | 9.1 | 3.0 |
| ROE % | 39.3 | 3.6 |
| Net Margin % | 20.9 | 3.8 |
| Rev Growth 5Y % | -0.5 | 9.9 |
| D/E | 1.0 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$29.09
$27.55 – $30.81
|
77.62B | 1 |
| FY2029 |
$25.94
$24.58 – $27.48
|
73.23B | 1 |
| FY2028 |
$23.68
$22.43 – $25.08
|
68.97B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-31 | N/A | $8.60 | — |
| 2025-07-24 | $13.18 | $5.81 | -55.9% |
| 2025-01-30 | $9.25 | $2.77 | -70.1% |
| 2024-10-23 | $10.42 | $8.71 | -16.4% |
| 2024-04-26 | $10.07 | $6.34 | -37.0% |
| 2023-11-29 | $11.62 | $9.90 | -14.8% |
| 2023-02-02 | $9.49 | $5.26 | -44.6% |
| 2022-07-21 | $11.53 | $10.99 | -4.7% |
Dividend History
6 yr streakYield
0.03%
Payout Ratio
0.65%
Growth (3Y)
3.45%
Growth (5Y)
3.79%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 13, 2026 | Mar 16, 2026 | $13.74 | 3.15% |
| Mar 28, 2025 | Mar 31, 2025 | $11.01 | 3.13% |
| Mar 14, 2024 | Mar 18, 2024 | $10.87 | 3.73% |
| Mar 16, 2023 | Mar 20, 2023 | $10.22 | 3.34% |
| Mar 17, 2022 | Mar 21, 2022 | $9.95 | 2.28% |
| Mar 18, 2021 | Mar 22, 2021 | $9.80 | 2.87% |
| Mar 19, 2020 | Mar 23, 2020 | $9.14 | 3.04% |
| Mar 07, 2019 | Mar 11, 2019 | $8.63 | 3.25% |
| Mar 15, 2018 | Mar 19, 2018 | $8.73 | 3.57% |
| Mar 16, 2017 | Mar 20, 2017 | $8.24 | 3.21% |
| Mar 03, 2016 | Mar 07, 2016 | $8.16 | 3.20% |
| Mar 05, 2015 | Mar 10, 2015 | $8.23 | 3.11% |
| Mar 06, 2014 | Mar 11, 2014 | $8.85 | 2.97% |
| Mar 07, 2013 | Mar 12, 2013 | $7.78 | 3.16% |
| Mar 08, 2012 | Mar 13, 2012 | $7.49 | 4.12% |
| Mar 03, 2011 | Mar 08, 2011 | $7.09 | 4.60% |
| Mar 04, 2010 | Mar 09, 2010 | $5.58 | 3.23% |
| Mar 16, 2009 | Mar 16, 2009 | $4.22 | 3.12% |
| Mar 07, 2008 | Mar 07, 2008 | $4.49 | 2.20% |
| Mar 08, 2007 | Mar 08, 2007 | $2.78 | 1.35% |
Puntos Clave
Revenue declined -0.50% annually over 5 years
Earnings grew 55.69% over the past year
ROE of 39.30% indicates high profitability
Net margin of 20.94% shows strong profitability
Generating 14.09B in free cash flow
PEG of 0.39 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
-0.50%
Revenue (1Y)-1.36%
Earnings (1Y)55.69%
FCF Growth (3Y)10.95%
Calidad
Return on Equity
39.30%
ROIC17.98%
Net Margin20.94%
Op. Margin26.59%
Seguridad
Debt / Equity
1.02
Current Ratio1.38
Interest Coverage12.13
Valoración
P/E Ratio
23.89
Forward P/E19.09
P/B Ratio9.10
EV/EBITDA20.57
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.36% | Revenue Growth (3Y) | 0.91% |
| Earnings Growth (1Y) | 55.69% | Earnings Growth (3Y) | 5.86% |
| Revenue Growth (5Y) | -0.50% | Earnings Growth (5Y) | -1.93% |
| Profitability | |||
| Revenue (TTM) | 61.55B | Net Income (TTM) | 12.89B |
| ROE | 39.30% | ROA | 12.79% |
| Gross Margin | 72.94% | Operating Margin | 26.59% |
| Net Margin | 20.94% | Free Cash Flow (TTM) | 14.09B |
| ROIC | 17.98% | FCF Growth (3Y) | 10.95% |
| Safety | |||
| Debt / Equity | 1.02 | Current Ratio | 1.38 |
| Interest Coverage | 12.13 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.65% |
| Dividend Growth (3Y) | 3.45% | Dividend Growth (5Y) | 3.79% |
| Consecutive Div Years | 6 yrs | ||
| Valuation | |||
| P/E Ratio | 23.89 | Forward P/E | 19.09 |
| P/B Ratio | 9.10 | P/S Ratio | 5.00 |
| PEG Ratio | 0.39 | Forward PEG | N/A |
| EV/EBITDA | 20.57 | Fwd EV/EBITDA | 16.09 |
| Forward P/S | 4.88 | Fwd Earnings Yield | 5.24% |
| FCF Yield | 4.58% | ||
| Market Cap | 307.85B | Enterprise Value | 336.72B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 61.55B | 62.40B | 60.44B | 63.28B | 62.80B |
| Net Income | 12.89B | 8.28B | 11.50B | 12.42B | 13.93B |
| EPS (Diluted) | 16.05 | 10.32 | 14.30 | 15.37 | 16.20 |
| Gross Profit | 44.89B | 46.11B | 44.08B | 42.88B | 43.15B |
| Operating Income | 16.37B | 13.42B | 15.40B | 17.48B | 18.16B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 100.75B | 101.80B | 90.47B | 88.15B | 92.32B |
| Total Liabilities | 62.85B | 65.64B | 57.21B | 56.14B | 63.97B |
| Shareholders' Equity | 33.82B | 31.77B | 29.32B | 27.99B | 24.49B |
| Total Debt | 34.45B | 36.35B | 30.78B | 26.54B | 32.55B |
| Cash & Equivalents | 5.58B | 6.98B | 5.38B | 4.99B | 6.85B |
| Current Assets | 38.75B | 40.04B | 33.45B | 33.82B | 35.63B |
| Current Liabilities | 28.01B | 27.02B | 24.82B | 27.24B | 38.42B |